The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression.
The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression.
复制标题
DOI：
10.1097/01.aog.0000465192.34779.dc
复制
发表时间：
2015-05-01
影响因子：
7.2
通讯作者：
中科院分区：
文献类型：
--
作者：
围产期抑郁症，包括在怀孕期间或分娩后的前12个月内发生的严重和轻微抑郁发作，是怀孕和产后期间最常见的医疗并发症之一，影响七分之一的妇女。识别患有抑郁症的孕妇和产后妇女非常重要，因为未经治疗的围产期抑郁症和其他情绪障碍可能对妇女，婴儿和家庭产生破坏性影响。一些筛查工具已经过验证，可用于怀孕期间和产后期间。虽然明确的证据是有限的，美国妇产科医师学会建议临床医生在围产期使用标准化的，有效的工具筛查患者至少一次抑郁和焦虑症状。虽然筛查对于检测围产期抑郁症很重要，但筛查本身不足以改善临床结局，必须在有指征时与适当的随访和治疗相结合;妇产科实践中的临床工作人员应准备启动药物治疗，将患者转诊至适当的行为健康资源。
Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting one in seven women. It is important to identify pregnant and postpartum women with depression because untreated perinatal depression and other mood disorders can have devastating effects on women, infants, and families. Several screening instruments have been validated for use during pregnancy and the postpartum period. Although definitive evidence of benefit is limited, the American College of Obstetricians and Gynecologists recommends that clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standardized, validated tool. Although screening is important for detecting perinatal depression, screening by itself is insufficient to improve clinical outcomes and must be coupled with appropriate follow-up and treatment when indicated; clinical staff in obstetrics and gynecology practices should be prepared to initiate medical therapy, refer patients to appropriate behavioral health resources when indicated, or both.